Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

Novo Nordisk, Eli Lilly and obesity

Digest more
 · 28m · on MSN
Novo Nordisk trims outlook as obesity drug maker loses ground to Eli Lilly
Pedersen, Maggie Fick and Bhanvi Satija COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year forecasts on Wednesday as sales growth of its blockbuster obesity drugs slows, leaving investors worried the firm is losing ground to U.

Continue reading

 · 19h · on MSN
Eli Lilly, Novo Nordisk negotiating deal with Trump administration on obesity drug prices
Fierce Pharma · 20h
Lilly, Novo Nordisk in pricing, coverage talks with Trump administration on obesity meds: Endpoints
19h

Eli Lilly, Novo Nordisk close to White House deal on obesity drug prices

The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...
Devdiscourse
4h

Novo Nordisk Under Siege: Battle for Weight-Loss Drug Supremacy

Novo Nordisk once dominated the weight-loss drug market with Wegovy. However, rising competition, particularly from Eli Lilly ...
6d

Novo Nordisk's bid for Metsera, Eli Lilly boosts revenue outlook

Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including Novo Nordisk's (NVO) bidding ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results
Feedback
  • Privacy
  • Terms